Current clinical studies have revealed that there are high-profile inflammatory markers in subjects with Crohn’s disease, specifically activated monocyte/macrophage-associated markers such as IL-1β and chemokine CXCL16. This evidence concerns the gene CXCL16 and Crohn disease.